Written question asked by Mark Eastwood (Conservative) on Friday, 10 November 2023, in the House of Commons. It was due for an answer on Tuesday, 14 November 2023. It was answered by Andrew Stephenson (Conservative) on Monday, 20 November 2023 on behalf of the Department of Health and Social Care.
Medical Treatments: Innovation
- Question
-
To ask the Secretary of State for Health and Social Care, with reference to the Answers of 16 October 2023 to Questions 200120, 200121, 200122 and 200123 on Medial Treatments: Innovation, which criteria within the MedTech Strategy Programme governance structures will be used to assess the range of initiatives.
- Answer
-
A key criterion is clear, meaningful metrics that directly align to the core priorities of the Strategy. We are working with system partners, industry and patient groups and other key stakeholders to develop meaningful metrics for each initiative and for the overall robust evaluation of the strategy.
Our previous answer, which you reference in your question, outlined the range of different initiatives we are progressing. Each initiative is at a different stage of progress and will work up individual, appropriate criteria with their key delivery partners. These will be reported to programme governance structures as they become available.
Secondary information
- Type
- Written question
- Reference
- 1400
- Session
- 2023-24
- Related items
- Subjects
- Innovation Medical treatments Technology
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2023-11-20 23:33:32 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2023-24/1400
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2023-24/1400
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2023-24/1400